Form 4 for WGS GeneDx Holdings Corp.

Accepted 2022-10-04 00:00:00 ET · period of report 2022-10-01 · accession 0001209191-22-052572 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-10-04	2022-10-01	WGS	Saad Kareem	Chief Transformation Off	M - OptEx	—	+9,005	86.0K	+12%	—
D	2022-10-04	2022-10-03	WGS	Saad Kareem	Chief Transformation Off	S - Sale+OE	$0.94	-2,669	83.3K	-3%	-$2,509
D	2022-10-04	2022-10-01	WGS	Saad Kareem	Chief Transformation Off	M - OptEx	$0.00	-9,005	135.1K	-6%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2022-10-01	M	A	9,005	—	85,997	D	—	—	(F1) Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2	Common	Class A Common Stock	2022-10-03	S	D	2,669	$0.94	83,328	D	—	—	(F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.8605 to $1.1143, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
3	Derivative	Restricted Stock Unit	2022-10-01	M	D	9,005	$0.00	135,081	D	— · — to —	9,005 Class A Common Stock	(F1) Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F4) 6.25% vest in quarterly installments over the 4-year period commencing on April 4, 2022 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.